Low-grade serous carcinoma of the ovary is a distinct histological subtype of ovarian cancer with specific management considerations, particularly regarding the approach taken after completion of adjuvant chemotherapy.
This protocol addresses patients with ovarian cancer confirmed as low-grade serous carcinoma — a subtype recognised for its unique biological behaviour and treatment pathway compared with high-grade serous carcinoma.
Following adjuvant chemotherapy, maintenance hormonal therapy is an established strategy in this setting. The full evidence-based protocol specifies the recommended options and the conditions under which each applies.